Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | XLO | INAB | ||
| Company | Catabasis Pharma | Xilio Therapeutics Inc | In8Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.21 | 1.0200 | 1.0000 | ||
| High | 9.21 | 1.1100 | 1.0400 | ||
| Low | 8.46 | 1.0200 | 0.9900 | ||
| Last | 8.54 | 1.0900 | 1.0400 | ||
| Change | -0.64 | +0.0800 | unch | ||
| % Change | -6.97% | +7.92% | unch | ||
| Volume | 98,800 | 144,100 | 55,900 | ||
| 20-Day Average Volume | 395,311 | 1,735,925 | 718,560 | ||
| Previous Close | 9.18 | 1.0100 | 1.0400 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 1.2425 | 1.0655 | ||
| 20-Day Raw Stochastic | 56.46% | 20.47% | 40.72% | ||
| 20-Day Relative Strength | 43.24% | 51.97% | 45.00% | ||
| Weighted Alpha | -50.43 | -70.89 | -58.66 | ||
| Today's Opinion | 88% Sell | 8% Sell | 88% Sell | ||
| Previous Opinion | 72% Sell | 8% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 80% Sell | 16% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | -5.22% since 04/19/24 | +0.97% since 04/19/24 | ||
| Low | 8.46 on 09/08/21 | 0.9510 on 04/25/24 | 0.9400 on 04/23/24 | ||
| High | 10.26 on 09/02/21 | 1.1800 on 04/22/24 | 1.0700 on 04/24/24 | ||
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | +65.33% since 03/26/24 | -16.80% since 03/26/24 | ||
| Low | 6.31 on 08/20/21 | 0.5800 on 03/27/24 | 0.9164 on 04/12/24 | ||
| High | 10.26 on 09/02/21 | 1.9300 on 03/28/24 | 1.2700 on 03/28/24 | ||
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | +67.69% since 01/26/24 | -20.00% since 01/26/24 | ||
| Low | 6.31 on 08/20/21 | 0.5001 on 02/14/24 | 0.9164 on 04/12/24 | ||
| High | 15.72 on 06/16/21 | 1.9300 on 03/28/24 | 1.4500 on 03/08/24 | ||
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | -47.60% since 10/26/23 | +4.00% since 10/26/23 | ||
| Low | 6.31 on 08/20/21 | 0.4900 on 12/20/23 | 0.6500 on 11/22/23 | ||
| High | 22.01 on 03/18/21 | 2.8938 on 11/03/23 | 2.4800 on 12/15/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 34,818 | 33,271 | ||
| Shares Outstanding, K | 3,904 | 34,473 | 31,991 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -37,300,000 | -76,400,000 | -30,010,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -7,470,000 | -17,660,000 | -7,600,000 | ||
| 60-Month Beta | 1.66 | -0.12 | -0.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.64 on 04/01/24 | -0.21 on 03/14/24 | ||
| Latest Earnings Date | 08/09/21 | 05/14/24 | 05/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||